Cargando…
Those Who Pay Have a Say: A View on Oncology Drug Pricing and Reimbursement
Four recommendations are made to address the high costs of cancer therapy: remove coverage mandates from state and federal insurance law, create performance transparency for drug regimens, cap profit margins for administering drugs, and place every patient with a genetic mutation in a clinical trial...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AlphaMed Press
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4943395/ https://www.ncbi.nlm.nih.gov/pubmed/27325749 http://dx.doi.org/10.1634/theoncologist.2016-0119 |